PSMB6

📖 Wiki Page

gene908 wordssynced 2026-04-02

PSMB6

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PSMB6</th>
</tr>
<tr>
<td class="label">Attribute</td>
<td>Value</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PSMB6</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Proteasome Subunit Beta 6</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5699</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>N/A</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000104613</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P28074</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>204 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~25 kDa</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Activity</td>
</tr>
<tr>
<td class="label">PSMB6 (β6)</td>
<td>Caspase-like (post-acidic)</td>
</tr>
<tr>
<td class="label">PSMB2 (β2)</td>
<td>Trypsin-like</td>
</tr>
<tr>
<td class="label">PSMB5 (β5)</td>
<td>Chymotrypsin-like</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Psmb6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

PSMB6

Introduction

Psmb6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

PSMB6 (Proteasome Subunit Beta 6) encodes the β6 catalytic subunit of the 20S proteasome core particle. This subunit provides the proteasome's caspase-like (or post-acidic) proteolytic activity, cleaving peptides after acidic residues. PSMB6 is essential for proper proteasome function and plays a critical role in protein homeostasis throughout the central nervous system. [@ubiquitinproteasome2019]

The proteasome is a key component of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) (UPS), which is responsible for degrading misfolded, oxidized, and regulatory proteins. In [neurons](/entities/neurons), where protein turnover is carefully regulated to maintain synaptic function and prevent aggregation, proteasome activity is particularly crucial. [@structure2019]

Gene Information

Protein Structure

PSMB6 is a catalytic β-subunit belonging to the Ntn-hydrolase family. The protein contains an N-terminal threonine residue (Thr1) that serves as the active site nucleophile for proteolysis.

Key Structural Features

N-terminal Thr active site: The catalytic threonine is exposed upon proteasome assembly
S1 pocket: Substrate binding pocket that recognizes basic residues
Catalytic core: Forms part of the proteasome's proteolytic chamber (β6 ring position)
Interaction interfaces: Contacts adjacent α and β subunits for proper assembly

Function in Protein Degradation

Proteasome Catalytic Activity

The 20S proteasome contains three distinct catalytic subunits with different substrate specificities:

PSMB6's caspase-like activity is essential for:

Degradation of regulatory proteins
Processing of transcription factors
Clearance of oxidized proteins
MHC class I antigen presentation

Role in Neuronal Protein Homeostasis

In neurons, the proteasome system is critical for:

Synaptic protein turnover
Axon guidance molecule degradation
Neurotransmitter receptor regulation
Clearance of misfolded proteins

Expression Pattern

Brain Expression

PSMB6 is ubiquitously expressed throughout the brain with high levels in:

Cerebral [cortex](/brain-regions/cortex): Pyramidal neurons and interneurons
[Hippocampus](/brain-regions/hippocampus): CA1-CA3 regions and dentate gyrus
Cerebellum: Purkinje cells and granule cells
Substantia nigra: Dopaminergic neurons
Spinal cord: Motor neurons

Cellular Localization

Cytoplasmic: Majority of proteasomes are cytosolic
Nuclear: Nuclear proteasomes regulate transcription factors
Synaptic: Local proteasome activity at synapses regulates synaptic plasticity

Role in Neurodegenerative Diseases

Alzheimer's Disease

Proteasome activity is significantly reduced in AD brain tissue, contributing to:

[Amyloid-beta](/proteins/amyloid-beta) accumulation due to impaired clearance
[Tau](/proteins/tau) protein aggregation
Synaptic protein dysfunction
Neuronal death

Research has shown that PSMB6 expression and activity are altered in AD:

[Proteasome subunit expression is dysregulated in AD](https://doi.org/10.1007/s00401-019-02034-8) (Acta Neuropathol, 2019)
Post-translational modifications of PSMB6 may impair catalytic activity
Oxidative stress in AD affects proteasome function

Parkinson's Disease

The [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) is central to PD pathogenesis:

[Alpha-synuclein](/proteins/alpha-synuclein) clearance relies on proteasomal degradation
Mutations in proteasome-related genes increase PD risk
Proteasome impairment contributes to Lewy body formation

Amyotrophic Lateral Sclerosis (ALS)

Proteasome dysfunction is observed in ALS motor neurons
[TDP-43](/mechanisms/tdp-43-proteinopathy) aggregation overwhelms proteasome capacity
Proteasome activators are being investigated as therapeutic targets

Therapeutic Implications

Proteasome-Targeted Therapies

While PSMB6 itself is not a direct drug target, understanding its function informs:

Proteasome modulators: Compounds that enhance or restore proteasome activity
Protein aggregation inhibitors: Agents that reduce toxic protein load
Gene therapy approaches: Viral vectors expressing proteasome subunits

Research Directions

Developing brain-penetrant proteasome activators
Understanding post-translational modifications of PSMB6
Investigating proteasome-stabilizing compounds

Animal Models

Knockout mice: PSMB6 deletion is embryonic lethal, highlighting essential function
Conditional knockouts: Neuron-specific deletion shows accumulation of ubiquitinated proteins
Transgenic models: Overexpression studies reveal protective effects against proteotoxic stress

Cross-Links

[26S Proteasome](/proteins/26s-proteasome)
[Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
[Protein Aggregation](/mechanisms/protein-aggregation)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)

External Links

[NCBI Gene: PSMB6](https://www.ncbi.nlm.nih.gov/gene/5692)
[UniProt: P60981](https://www.uniprot.org/uniprotkb/P60981)
[Ensembl: ENSG00000100982](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100982)
[GeneCards: PSMB6](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMB6)

Background

The study of Psmb6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Unknown, Proteasome subunit alterations in neurodegenerative disease brains (2019)](https://doi.org/10.1007/s00401-019-02034-8)

[Unknown, The ubiquitin-proteasome system in Alzheimer's disease pathogenesis (2019)](https://doi.org/10.1007/s00401-019-02067-5)

[Unknown, Structure of the human 20S proteasome (2019)](https://doi.org/10.1016/j.tibs.2019.06.005)

[Unknown, Proteasome dysfunction in Parkinson's disease (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.02.019)

[Unknown, Caspase-like activity of the proteasome (2018)](https://doi.org/10.1016/j.jmb.2018.09.013)

[Unknown, Neuronal proteostasis and neurodegenerative disease (2020)](https://doi.org/10.1016/j.neuron.2020.09.015)

[Unknown, Oxidative stress and proteasome function (2019)](https://doi.org/10.1016/j.freeradbiomed.2019.11.032)

[Unknown, Therapeutic targeting of the proteasome in neurodegeneration (2021)](https://doi.org/10.1038/s41582-021-00512-8)

📖 View canonical wiki page →

PSMB6

PSMB6

Introduction

PSMB6

Introduction

Overview

Gene Information

Protein Structure

Key Structural Features

Function in Protein Degradation

Proteasome Catalytic Activity

Role in Neuronal Protein Homeostasis

Expression Pattern

Brain Expression

Cellular Localization

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Implications

Proteasome-Targeted Therapies

Research Directions

Animal Models

Cross-Links

See Also

External Links

Background

References